388870 — Pharos IBio Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩147bn
- KR₩125bn
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -31,471 | -17,062 | -8,858 |
Depreciation | |||
Amortisation | |||
Non-Cash Items | 24,285 | 8,107 | -6.58 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -484 | 193 | 767 |
Change in Accounts Receivable | |||
Change in Prepaid Expenses | |||
Change in Accounts Payable | |||
Change in Accrued Expenses | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -7,319 | -8,184 | -7,413 |
Capital Expenditures | -1,481 | -334 | -855 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | -76.7 | -6,233 | 1,329 |
Sale of Fixed Assets | |||
Sale/Maturity of Investment | |||
Purchase of Investments | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | -1,557 | -6,567 | 474 |
Financing Cash Flow Items | -2 | — | — |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 17,635 | -271 | 18,805 |
Foreign Exchange Effects | |||
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 9,005 | -15,000 | 11,776 |